{"entity":{"type":"insider","cik":"0001274173","url":"/insider/0001274173","json_url":"/insider/0001274173.json","name":"JANUS HENDERSON GROUP PLC","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001274173"},"coverage_statement":{"n_transactions":15,"n_filings":3,"first":"2024-07-12","last":"2024-08-20","span_basis":"filed_date"},"name_variants":[{"name":"JANUS HENDERSON GROUP PLC","source":"filing","n_filings":3,"first_seen":"2024-07-12","last_seen":"2024-08-20"}],"transactions":[{"id":2556752,"accession":"0001437749-24-027344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-027344","line_url":"/filing/0001437749-24-027344#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5390.0,"shares_display":"5,390","price_per_share":2.93,"price_display":"2.93","price_state":"stated","total_value":15792.7,"total_display":"15,792.70","shares_owned_after":2116785.0,"shares_owned_after_display":"2,116,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider"},{"id":2556746,"accession":"0001437749-24-027344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-027344","line_url":"/filing/0001437749-24-027344#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":428.0,"shares_display":"428","price_per_share":2.9768,"price_display":"2.98","price_state":"stated","total_value":1274.0704,"total_display":"1,274.07","shares_owned_after":2117213.0,"shares_owned_after_display":"2,117,213","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider"},{"id":2103663,"accession":"0001437749-24-023533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-24-023533","line_url":"/filing/0001437749-24-023533#line-4","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Janus Henderson Biotech Innovation Master Fund Ltd; JANUS HENDERSON GROUP PLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30227.0,"shares_display":"30,227","price_per_share":3.0533,"price_display":"3.05","price_state":"stated","total_value":92292.0991,"total_display":"92,292.10","shares_owned_after":2111395.0,"shares_owned_after_display":"2,111,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-26","scope":"insider"},{"id":2103660,"accession":"0001437749-24-023533","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-24-023533","line_url":"/filing/0001437749-24-023533#line-3","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Janus Henderson Biotech Innovation Master Fund Ltd; JANUS HENDERSON GROUP PLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":165000.0,"shares_display":"165,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":528000.0,"total_display":"528,000.00","shares_owned_after":2056312.0,"shares_owned_after_display":"2,056,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":2103657,"accession":"0001437749-24-023533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-023533","line_url":"/filing/0001437749-24-023533#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Janus Henderson Biotech Innovation Master Fund Ltd; JANUS HENDERSON GROUP PLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17800.0,"shares_display":"17,800","price_per_share":3.1795,"price_display":"3.18","price_state":"stated","total_value":56595.1,"total_display":"56,595.10","shares_owned_after":2074112.0,"shares_owned_after_display":"2,074,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":2103652,"accession":"0001437749-24-023533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-023533","line_url":"/filing/0001437749-24-023533#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Janus Henderson Biotech Innovation Master Fund Ltd; JANUS HENDERSON GROUP PLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7056.0,"shares_display":"7,056","price_per_share":3.1573,"price_display":"3.16","price_state":"stated","total_value":22277.9088,"total_display":"22,277.91","shares_owned_after":2081168.0,"shares_owned_after_display":"2,081,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":2224293,"accession":"0001437749-24-022708","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-9","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94537.0,"shares_display":"94,537","price_per_share":3.4516,"price_display":"3.45","price_state":"stated","total_value":326303.9092,"total_display":"326,303.91","shares_owned_after":1891312.0,"shares_owned_after_display":"1,891,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-12","scope":"insider"},{"id":2224291,"accession":"0001437749-24-022708","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-8","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33500.0,"shares_display":"33,500","price_per_share":3.4647,"price_display":"3.46","price_state":"stated","total_value":116067.45,"total_display":"116,067.45","shares_owned_after":1774812.0,"shares_owned_after_display":"1,774,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2224289,"accession":"0001437749-24-022708","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-7","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21963.0,"shares_display":"21,963","price_per_share":3.4632,"price_display":"3.46","price_state":"stated","total_value":76062.2616,"total_display":"76,062.26","shares_owned_after":1796775.0,"shares_owned_after_display":"1,796,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2224286,"accession":"0001437749-24-022708","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-6","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16917.0,"shares_display":"16,917","price_per_share":3.4339,"price_display":"3.43","price_state":"stated","total_value":58091.2863,"total_display":"58,091.29","shares_owned_after":1741312.0,"shares_owned_after_display":"1,741,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-12","scope":"insider"},{"id":2224283,"accession":"0001437749-24-022708","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-5","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29892.0,"shares_display":"29,892","price_per_share":3.4114,"price_display":"3.41","price_state":"stated","total_value":101973.5688,"total_display":"101,973.57","shares_owned_after":1706795.0,"shares_owned_after_display":"1,706,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-07-12","scope":"insider"},{"id":2224281,"accession":"0001437749-24-022708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-4","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17600.0,"shares_display":"17,600","price_per_share":3.535,"price_display":"3.54","price_state":"stated","total_value":62216.0,"total_display":"62,216.00","shares_owned_after":1724395.0,"shares_owned_after_display":"1,724,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-07-12","scope":"insider"},{"id":2224279,"accession":"0001437749-24-022708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-3","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23326.0,"shares_display":"23,326","price_per_share":3.4303,"price_display":"3.43","price_state":"stated","total_value":80015.1778,"total_display":"80,015.18","shares_owned_after":1671903.0,"shares_owned_after_display":"1,671,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-12","scope":"insider"},{"id":2224276,"accession":"0001437749-24-022708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.41,"price_display":"3.41","price_state":"stated","total_value":17050.0,"total_display":"17,050.00","shares_owned_after":1676903.0,"shares_owned_after_display":"1,676,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-12","scope":"insider"},{"id":2224273,"accession":"0001437749-24-022708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-022708","line_url":"/filing/0001437749-24-022708#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"JANUS HENDERSON GROUP PLC; Janus Henderson Biotech Innovation Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166042.0,"shares_display":"166,042","price_per_share":3.5507,"price_display":"3.55","price_state":"stated","total_value":589565.3294,"total_display":"589,565.33","shares_owned_after":1648577.0,"shares_owned_after_display":"1,648,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Ten percent owner","n_filings":3,"first_seen":"2024-07-12","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001274173","retrieved_at":"2026-08-21T12:03:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}